Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

OBJECTIVES: To examine the effectiveness of tocilizumab (TCZ) with and without synthetic disease-modifying antirheumatic drugs (sDMARDs) in a large observational study. METHODS: Patients with rheumatoid arthritis treated with TCZ who had a baseline visit and information on concomitant sDMARDs were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabay, Cem, Riek, Myriam, Hetland, Merete Lund, Hauge, Ellen-Margrethe, Pavelka, Karel, Tomšič, Matija, Canhao, Helena, Chatzidionysiou, Katerina, Lukina, Galina, Nordström, Dan C, Lie, Elisabeth, Ancuta, Ioan, Hernández, M Victoria, van Riel, Piet L M C, van Vollenhoven, Ronald, Kvien, Tore K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941183/
https://www.ncbi.nlm.nih.gov/pubmed/26374404
http://dx.doi.org/10.1136/annrheumdis-2015-207760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941183/
https://www.ncbi.nlm.nih.gov/pubmed/26374404
http://dx.doi.org/10.1136/annrheumdis-2015-207760

Ejemplares similares